Studies have shown that in patients with rheumatoid arthritis, Treg cells express CTLA-4, thereby exerting immunosuppressive effects, a process closely associated with the enhanced function and upregulated activity of IDO1.37 Here, CTLA4 is linked to rheumatoid arthritis.